Susan Lang
Susan L. Lang founded XIL Health, a leading, woman-owned health analytics and technology company. As CEO, Lang works with startups as well as Fortune 100 PBMs, health plans, drug manufacturers and retail pharmacy companies. In 2020, XIL Health launched XIL Impact, a SaaS technology platform that provides real time analytics and economics to pharmacy clients. Previously, Lang served as a C-Suite executive at Express Scripts where her division drove earnings growth that saved billions in drug costs. Lang has a robust knowledge of pharmaceutical economics and healthcare technology and is passionate about helping companies compete by leveraging disruptive technologies that …
Susan L. Lang founded XIL Health, a leading, woman-owned health analytics and technology company. As CEO, Lang works with startups as well as Fortune 100 PBMs, health plans, drug manufacturers and retail pharmacy companies. In 2020, XIL Health launched XIL Impact, a SaaS technology platform that provides real time analytics and economics to pharmacy clients. Previously, Lang served as a C-Suite executive at Express Scripts where her division drove earnings growth that saved billions in drug costs. Lang has a robust knowledge of pharmaceutical economics and healthcare technology and is passionate about helping companies compete by leveraging disruptive technologies that redistribute drug economics to benefit consumers.
See more
Articles: Susan Lang
2021 Drug Formulary Exclusions Continue to Reduce Therapy Choice for US Consumers
USA / Susan L. Lang outlines how pharma companies can navigate drug formulary exclusions, numbers of which have been rising in recent years, and ensure that newly FDA approved medicines can make it to consumers. The pipeline for new therapies at the Food and Drug Administration mostly consists of novel brand or specialty drugs waiting for…
Latest Report
